Lapenza (Olanzapine)

Olanzapine blocks dopamine D2 and serotonin 5‑HT2A receptors, reducing over‑activity of these pathways that contribute to psychosis and mood swings. It also influences histamine, muscarinic and adrenergic receptors, which together help to calm agitation, improve thought organization, and stabilize mood.

The specific dose of Lapenza is determined by the prescribing clinician based on the individual’s diagnosis, severity of symptoms, previous treatment response, and overall health. Dosage may be started low and adjusted gradually; patients should follow the prescriber’s instructions and not change the dose on their own.

Safety data for olanzapine in pregnancy and lactation are limited. The drug should only be used if the potential benefit justifies any possible risk to the fetus or infant. Women who are pregnant, planning pregnancy, or breastfeeding should discuss alternatives and monitoring plans with their healthcare provider.

To request Lapenza, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Compared with first‑generation antipsychotics, olanzapine (Lapenza) generally offers lower rates of extrapyramidal symptoms but has a higher propensity for metabolic side effects such as weight gain and glucose elevation. Its broad receptor profile provides effective control of both psychotic and mood symptoms, making it a common choice for schizophrenia and bipolar disorder.

Lapenza should be stored at room temperature, below 25 °C, in its original packaging. Keep the product away from moisture, direct sunlight and excessive heat. Do not store in the bathroom or near a kitchen sink to maintain stability and potency.

Lapenza is taken orally, usually as a tablet or capsule, with or without food as directed by the prescriber. Swallow the dose whole with a glass of water; do not crush or chew unless specifically instructed. Consistent timing each day helps maintain stable blood levels.

Serious risks include neuroleptic malignant syndrome, severe hyperglycemia, agranulocytosis, seizures, tardive dyskinesia and myocarditis. Patients should be monitored for fever, muscle rigidity, rapid heart rate, sudden changes in blood sugar, unexplained infections or involuntary movements, and report any concerning symptoms promptly.

Lapenza is contraindicated in individuals with known hypersensitivity to olanzapine or any of its excipients. It should be used with caution in patients with uncontrolled diabetes, severe cardiovascular disease, liver impairment, or a history of seizures. Pregnant or breastfeeding women should only use it when clearly indicated by a physician.